133 related articles for article (PubMed ID: 21425986)
1. Direct Rel/NF-κB inhibitors: structural basis for mechanism of action.
Ouk S; Liou ML; Liou HC
Future Med Chem; 2009 Dec; 1(9):1683-707. PubMed ID: 21425986
[TBL] [Abstract][Full Text] [Related]
2. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC; Gilmore TD
Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
[TBL] [Abstract][Full Text] [Related]
3. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways.
Kang JS; Yoon YD; Han MH; Han SB; Lee K; Lee KH; Park SK; Kim HM
Mol Pharmacol; 2006 Mar; 69(3):941-9. PubMed ID: 16354764
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of NF-kappaB signaling: 785 and counting.
Gilmore TD; Herscovitch M
Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the NF-kappaB signalling pathway by ergolide, sesquiterpene lactone, in HeLa cells.
Chun JK; Seo DW; Ahn SH; Park JH; You JS; Lee CH; Lee JC; Kim YK; Han JW
J Pharm Pharmacol; 2007 Apr; 59(4):561-6. PubMed ID: 17430640
[TBL] [Abstract][Full Text] [Related]
6. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
[TBL] [Abstract][Full Text] [Related]
7. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
8. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
9. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
10. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
[TBL] [Abstract][Full Text] [Related]
11. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens.
Leung CH; Grill SP; Lam W; Han QB; Sun HD; Cheng YC
Mol Pharmacol; 2005 Aug; 68(2):286-97. PubMed ID: 15872117
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity.
Liang MC; Bardhan S; Pace EA; Rosman D; Beutler JA; Porco JA; Gilmore TD
Biochem Pharmacol; 2006 Feb; 71(5):634-45. PubMed ID: 16360644
[TBL] [Abstract][Full Text] [Related]
13. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation.
Sun Q; Matta H; Lu G; Chaudhary PM
Oncogene; 2006 May; 25(19):2717-26. PubMed ID: 16418726
[TBL] [Abstract][Full Text] [Related]
14. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
15. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
16. Multiple redox regulation in NF-kappaB transcription factor activation.
Piette J; Piret B; Bonizzi G; Schoonbroodt S; Merville MP; Legrand-Poels S; Bours V
Biol Chem; 1997 Nov; 378(11):1237-45. PubMed ID: 9426183
[TBL] [Abstract][Full Text] [Related]
17. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
18. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
Lopez-Guerra M; Colomer D
Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
Van Waes C
Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]